title: Recognizing and reporting adverse drug reactions.
abstract: Although physicians in practice are most likely to see patients with adverse drug reactions, they may fail to recognize an adverse effect or to attribute it to a drug effect and, when recognized, they may fail to report serious reactions to the US Food and Drug Administration (FDA). To recognize and attribute an adverse event to a drug effect, physicians should review the patient's clinical course, looking at patient risk factors, the known adverse reactions to the suspected drug, and the likelihood of a causal relationship between the drug and the adverse event-based on the temporal relationship, response to stopping or restarting the drug, and whether other factors could explain the reaction. Once an adverse drug reaction has been identified, the patient should be informed and appropriate documentation made in the patient's medical record. Serious known reactions and all reactions to newly released drugs or those not previously known to occur (even if the certainty is low) should be reported to the FDA.
authors.affiliation: Division of General Medicine, Oregon Health Sciences University, Portland.
authors.forename: L M
authors.initials: LM
authors.lastname: Lucas
authors.forename: C A
authors.initials: CA
authors.lastname: Colley
mesh_terms: D000328:Adult; D016907:Adverse Drug Reaction Reporting Systems; D003657:Decision Making; D064420:Drug-Related Side Effects and Adverse Reactions; D005483:Flushing / Q000139:chemically induced; D005839:Gentamicins / Q000009:adverse effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D008297:Male; D008801:Mexiletine / Q000009:adverse effects; D008875:Middle Aged; D014481:United States; D014486:United States Food and Drug Administration; D014581:Urticaria / Q000139:chemically induced; D014640:Vancomycin / Q000009:adverse effects
chemical_list: D005839:Gentamicins; D008801:Mexiletine; D014640:Vancomycin